(c)
whether scientific advice relating to the clinical trial or the investigational medicinal product has been given by the Agency, a Member State or a third country;
← anx_I__cpt_2__point_7__point_b__text_1 · All articles · anx_I__cpt_2__point_7__point_c__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.